Catalent Gelecekteki Büyüme
Future kriter kontrolleri 3/6
Catalent is forecast to grow earnings and revenue by 98.4% and 6.8% per annum respectively. EPS is expected to grow by 104.1% per annum. Return on equity is forecast to be 9% in 3 years.
Anahtar bilgiler
98.4%
Kazanç büyüme oranı
104.1%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 19.4% |
Gelir büyüme oranı | 6.8% |
Gelecekteki özkaynak getirisi | 9.0% |
Analist kapsamı | Good |
Son güncelleme | 15 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
6/30/2027 | 5,380 | 361 | N/A | N/A | 1 |
6/30/2026 | 5,056 | 152 | N/A | 756 | 8 |
6/30/2025 | 4,692 | 41 | 39 | 482 | 9 |
6/30/2024 | 4,381 | -1,043 | -59 | 268 | N/A |
3/31/2024 | 4,135 | -1,176 | -123 | 250 | N/A |
12/31/2023 | 4,098 | -1,302 | -263 | 174 | N/A |
9/30/2023 | 4,223 | -1,015 | -235 | 276 | N/A |
6/30/2023 | 4,263 | -256 | -322 | 254 | N/A |
3/31/2023 | 4,495 | 21 | -563 | 127 | N/A |
12/31/2022 | 4,731 | 389 | -371 | 329 | N/A |
9/30/2022 | 4,799 | 399 | -471 | 184 | N/A |
6/30/2022 | 4,802 | 483 | -221 | 439 | N/A |
3/31/2022 | 4,703 | 485 | -110 | 504 | N/A |
12/31/2021 | 4,483 | 561 | -183 | 441 | N/A |
9/30/2021 | 4,177 | 544 | -244 | 446 | N/A |
6/30/2021 | 3,998 | 529 | -253 | 433 | N/A |
3/31/2021 | 3,757 | 494 | -188 | 471 | N/A |
12/31/2020 | 3,465 | 289 | -135 | 518 | N/A |
9/30/2020 | 3,275 | 250 | 22 | 565 | N/A |
6/30/2020 | 3,094 | 173 | -26 | 440 | N/A |
3/31/2020 | 2,872 | 104 | -37 | 356 | N/A |
12/31/2019 | 2,729 | 124 | 20 | 309 | N/A |
9/30/2019 | 2,631 | 138 | -22 | 232 | N/A |
6/30/2019 | 2,518 | 132 | 30 | 248 | N/A |
3/31/2019 | 2,478 | 149 | 75 | 263 | N/A |
12/31/2018 | 2,488 | 136 | 108 | 283 | N/A |
9/30/2018 | 2,471 | 65 | 160 | 332 | N/A |
6/30/2018 | 2,463 | 84 | 198 | 375 | N/A |
3/31/2018 | 2,395 | 63 | N/A | 371 | N/A |
12/31/2017 | 2,300 | 70 | N/A | 380 | N/A |
9/30/2017 | 2,177 | 109 | N/A | 335 | N/A |
6/30/2017 | 2,075 | 110 | N/A | 300 | N/A |
3/31/2017 | 1,991 | 106 | N/A | 233 | N/A |
12/31/2016 | 1,896 | 91 | N/A | 180 | N/A |
9/30/2016 | 1,867 | 104 | N/A | 159 | N/A |
6/30/2016 | 1,848 | 112 | N/A | 155 | N/A |
3/31/2016 | 1,826 | 207 | N/A | 199 | N/A |
12/31/2015 | 1,835 | 228 | N/A | 243 | N/A |
9/30/2015 | 1,836 | 244 | N/A | 257 | N/A |
6/30/2015 | 1,831 | 212 | N/A | 172 | N/A |
3/31/2015 | 1,840 | 86 | N/A | 180 | N/A |
12/31/2014 | 1,847 | 62 | N/A | 138 | N/A |
9/30/2014 | 1,832 | -3 | N/A | 113 | N/A |
6/30/2014 | 1,828 | 19 | N/A | 178 | N/A |
3/31/2014 | 1,813 | 2 | N/A | 148 | N/A |
12/31/2013 | 1,807 | -20 | N/A | 152 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: CTLT * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (7.9%).
Kazançlar ve Piyasa: CTLT * is forecast to become profitable over the next 3 years, which is considered above average market growth.
Yüksek Büyüme Kazançları: CTLT * is expected to become profitable in the next 3 years.
Gelir ve Pazar: CTLT *'s revenue (6.8% per year) is forecast to grow slower than the MX market (7.2% per year).
Yüksek Büyüme Geliri: CTLT *'s revenue (6.8% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: CTLT *'s Return on Equity is forecast to be low in 3 years time (9%).